Cargando…
Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent
Cancer cells often accumulate spontaneous and treatment-induced DNA damage i.e. potentially lethal DNA double strand breaks (DSBs). Targeting DSB repair mechanisms with specific inhibitors could potentially sensitize cancer cells to the toxic effect of DSBs. Current treatment for glioblastoma includ...
Autores principales: | Toma, Monika, Witusik-Perkowska, Monika, Szwed, Marzena, Stawski, Robert, Szemraj, Janusz, Drzewiecka, Malgorzata, Nieborowska-Skorska, Margaret, Radek, Maciej, Kolasa, Pawel, Matlawska-Wasowska, Ksenia, Sliwinski, Tomasz, Skorski, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305145/ https://www.ncbi.nlm.nih.gov/pubmed/30627327 http://dx.doi.org/10.18632/oncotarget.26409 |
Ejemplares similares
-
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas
por: Czyż, Małgorzata, et al.
Publicado: (2016) -
Relationship between Oxidative Stress and Imatinib Resistance in Model Chronic Myeloid Leukemia Cells
por: Głowacki, Sylwester, et al.
Publicado: (2021) -
AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells
por: Nieborowska-Skorska, Margaret, et al.
Publicado: (2014) -
Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
por: Sullivan-Reed, Katherine, et al.
Publicado: (2018) -
Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells
por: Drzewiecka, Małgorzata, et al.
Publicado: (2023)